Lantern Pharma (LTRN) Earnings
|
Expand Research on LTRN
| Next EPS Date | 11/11/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +22.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +9.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/26 |
Q226 | N/A | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/11/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/5/26 |
Q126 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/13/26 |
Q425 | N/A | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.54 | N/A | N/A | N/A | N/A | N/A | N/A |
